ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,173.20
1.85%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36602
-0.05%
Bitcoin
59,630.27
0.86%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) News

YMAB Y mAbs Therapeutics Inc

17.25
0.76 (4.61%)
May 02 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.76 4.61% 17.25 16:30:00
Open Price Low Price High Price Close Price Previous Close
16.49 16.295 17.39 17.25 16.49
more quote information »

Recent News

Date Time Source Heading
4/26/202406:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
4/25/202415:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
3/14/202408:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
3/07/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:49EDGAR2Form 144 - Report of proposed sale of securities
3/06/202415:40EDGAR2Form 144 - Report of proposed sale of securities
3/05/202418:05EDGAR2Form 144 - Report of proposed sale of securities
3/04/202406:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
3/04/202405:05EDGAR2Form 8-K - Current report
2/29/202416:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/29/202415:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
2/29/202415:04EDGAR2Form 8-K - Current report
2/16/202406:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
2/14/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202414:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202405:45EDGAR2Form 8-K - Current report
1/02/202415:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
12/26/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202315:40EDGAR2Form 144 - Report of proposed sale of securities
12/13/202315:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
12/12/202307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202315:07EDGAR2Form 144 - Report of proposed sale of securities
11/13/202315:47EDGAR2Form 8-K - Current report
11/13/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:05GLOBEY-mAbs Reports Third Quarter 2023 Financial Results and..
11/08/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202316:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/31/202306:05GLOBEY-mAbs to Announce Third Quarter 2023 Financial and..
10/18/202315:09EDGAR2Form 8-K - Current report
10/18/202315:05GLOBEY-mAbs Names Michael Rossi as President and Chief Executive..
10/18/202308:00EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
YMAB
Y mAbs Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved